SK bioscience Appoints New Executives towards Global Business Growth
yahoo.com
finance
2022-10-21 12:00:00

Global experts continue to join SK bioscience, while its U.S. corporate entity is being established

Company plans to strategically invest in personnel, innovation & infrastructure to ensure global competitiveness

SEOUL, South Korea, Oct. 21, 2022 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure across the globe, today announced that Dr. Harry Kleanthous, formerly Senior Program Officer in Global Health at the Bill & Melinda Gates Foundation (BMGF), has joined the Company as Executive Vice President of Vaccine R&D Strategy and External Innovation.
